177 related articles for article (PubMed ID: 16472751)
1. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.
Chrencik JE; Brooun A; Recht MI; Kraus ML; Koolpe M; Kolatkar AR; Bruce RH; Martiny-Baron G; Widmer H; Pasquale EB; Kuhn P
Structure; 2006 Feb; 14(2):321-30. PubMed ID: 16472751
[TBL] [Abstract][Full Text] [Related]
2. Selectivity and promiscuity in Eph receptors.
Haramis AP; Perrakis A
Structure; 2006 Feb; 14(2):169-71. PubMed ID: 16472735
[No Abstract] [Full Text] [Related]
3. Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity.
Chrencik JE; Brooun A; Kraus ML; Recht MI; Kolatkar AR; Han GW; Seifert JM; Widmer H; Auer M; Kuhn P
J Biol Chem; 2006 Sep; 281(38):28185-92. PubMed ID: 16867992
[TBL] [Abstract][Full Text] [Related]
4. NMR structure and dynamics of human ephrin-B2 ectodomain: the functionally critical C-D and G-H loops are highly dynamic in solution.
Ran X; Qin H; Liu J; Fan JS; Shi J; Song J
Proteins; 2008 Aug; 72(3):1019-29. PubMed ID: 18300229
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the ephrin-B1 ectodomain: implications for receptor recognition and signaling.
Nikolov DB; Li C; Barton WA; Himanen JP
Biochemistry; 2005 Aug; 44(33):10947-53. PubMed ID: 16101278
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
Himanen JP; Henkemeyer M; Nikolov DB
Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of an Eph receptor-ephrin complex.
Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB
Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069
[TBL] [Abstract][Full Text] [Related]
9. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
10. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.
Duggineni S; Mitra S; Noberini R; Han X; Lin N; Xu Y; Tian W; An J; Pasquale EB; Huang Z
Biochem Pharmacol; 2013 Feb; 85(4):507-13. PubMed ID: 23253822
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition.
Chrencik JE; Brooun A; Recht MI; Nicola G; Davis LK; Abagyan R; Widmer H; Pasquale EB; Kuhn P
J Biol Chem; 2007 Dec; 282(50):36505-13. PubMed ID: 17897949
[TBL] [Abstract][Full Text] [Related]
13. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
Koolpe M; Burgess R; Dail M; Pasquale EB
J Biol Chem; 2005 Apr; 280(17):17301-11. PubMed ID: 15722342
[TBL] [Abstract][Full Text] [Related]
14. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK; Foos G; Hauser CA; Pasquale EB
Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
[TBL] [Abstract][Full Text] [Related]
15. Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).
Lafleur K; Huang D; Zhou T; Caflisch A; Nevado C
J Med Chem; 2009 Oct; 52(20):6433-46. PubMed ID: 19788238
[TBL] [Abstract][Full Text] [Related]
16. Chemometrical classification of ephrin ligands and Eph kinases using GRID/CPCA approach.
Myshkin E; Wang B
J Chem Inf Comput Sci; 2003; 43(3):1004-10. PubMed ID: 12767159
[TBL] [Abstract][Full Text] [Related]
17. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.
Favelyukis S; Till JH; Hubbard SR; Miller WT
Nat Struct Biol; 2001 Dec; 8(12):1058-63. PubMed ID: 11694888
[TBL] [Abstract][Full Text] [Related]
18. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.
Qin H; Noberini R; Huan X; Shi J; Pasquale EB; Song J
J Biol Chem; 2010 Jan; 285(1):644-54. PubMed ID: 19875447
[TBL] [Abstract][Full Text] [Related]
20. A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis.
Suenobu S; Takakura N; Inada T; Yamada Y; Yuasa H; Zhang XQ; Sakano S; Oike Y; Suda T
Biochem Biophys Res Commun; 2002 May; 293(3):1124-31. PubMed ID: 12051776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
